Abeona Therapeutics Inc
NASDAQ:ABEO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abeona Therapeutics Inc
NASDAQ:ABEO
|
US |
|
D
|
Dave and Buster's Entertainment, Inc
F:9DB
|
US |
Intrinsic Value
The intrinsic value of Abeona Therapeutics Inc (ABEO) under the Base Case is 9.634 USD per share.
Compared with the current market price of 4.405 USD, the stock appears
Undervalued by 54% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Abeona Therapeutics Does
Abeona Therapeutics is a biotechnology company focused on gene and cell therapies for rare genetic diseases. It tries to fix the underlying DNA problem behind a disorder, rather than just treating symptoms. Its work has centered on diseases that affect the eyes, the immune system, and other inherited conditions with very limited treatment options.
- Headquarters
- United States of America US
- Employees
- 226
- IPO date
- Sep 19, 1980
Revenue & Expenses Breakdown
Abeona Therapeutics Inc
Earnings Waterfall
Abeona Therapeutics Inc
The intrinsic value for Abeona Therapeutics Inc (ABEO) under the Base Case is 9.634 USD.
Compared with the current market price of 4.405 USD, the stock appears Undervalued by 54% .